<p>OmniAb, Inc.（纳斯达克代码：OABI - 获取免费报告）首席执行官 Matthew Foehr 于 12 月 8 日星期一出售了 13,666 股公司的股票。股票以平均价格 1.96 美元出售，总价值为 26,785.36 美元。出售完成后，首席执行官在公司中持有 4,360,083 股，价值为 8,545,762.68 美元。这代表其持股比例下降了 0.31%。该交易已在向 SEC 提交的文件中披露，文件可通过此链接获取。</p>
<h2>OmniAb 价格表现</h2>
<p>纳斯达克 OABI 于周二开盘价为 1.99 美元。该公司的市值为 2.8648 亿美元，市盈率为-3.43，贝塔值为 0.13。该股票的 50 日移动平均价为 1.65 美元，200 日移动平均价为 1.71 美元。OmniAb, Inc.的 1 年最低价为 1.22 美元，1 年最高价为 4.17 美元。</p>
<p>OmniAb（纳斯达克：OABI - 获取免费报告）最近于 11 月 4 日星期二发布了季度财报。公司报告本季度每股收益（EPS）为-0.14 美元，超出市场共识预期的-0.15 美元 0.01 美元。该季度的收入为 224 万美元，而分析师预期为 564 万美元。OmniAb 的净利润率为-301.83%，股本回报率为-23.14%。分析师平均预计 OmniAb, Inc.在当前财政年度的每股收益为-0.61 美元。</p>
<h2>对 OmniAb 的对冲基金看法</h2>
<p>一些机构投资者和对冲基金最近增加或减少了对该公司的持股。Nuveen LLC 在第一季度收购了 OmniAb 的新股份，价值约为 547,000 美元。俄亥俄州公共雇员退休系统在第二季度购买了 OmniAb 的新股份，价值 168,000 美元。PNC 金融服务集团在第一季度将其在 OmniAb 的持股增加了 279.4%。PNC 金融服务集团目前持有 16,276 股公司股票，价值 39,000 美元，此前在上个季度增持了 11,986 股。Connors 投资服务公司在第二季度将其在 OmniAb 的持股提高了 25.0%。Connors 投资服务公司目前持有 62,000 股公司股票，价值 108,000 美元，此前在上个季度增持了 12,389 股。最后，Towerview LLC 在第二季度将其在 OmniAb 的持股增加了 43.3%。Towerview LLC 目前持有 831,100 股公司股票，价值 1,446,000 美元，此前在上个季度增持了 251,100 股。72.08% 的股票由机构投资者和对冲基金持有。</p>
<h2>分析师评级变动</h2>
<p>另外，Weiss Ratings 在 12 月 1 日星期一的一份研究报告中重申了对 OmniAb 股票的 “卖出（d-）” 评级。三位投资分析师对该股票给予了买入评级，一位分析师给予了卖出评级。根据 MarketBeat 的数据，该股票目前的平均评级为 “适度买入”，共识目标价为 6.67 美元。</p>
<p><strong>查看我们关于 OABI 的最新研究报告</strong></p>
<h2>OmniAb 公司简介</h2>
<p>（获取免费报告）</p>
<p>OmniAb, Inc.是一家生物技术公司，专注于在美国发现和提供治疗性抗体发现技术。公司的技术平台创建并筛选多样的抗体库，并为合作伙伴的药物开发工作识别最佳抗体。</p>
<h2>进一步阅读</h2>
<ul>
<li>我们更看好的五只股票而非 OmniAb</li>
<li>什么是低市盈率，它对投资者意味着什么？</li>
<li>为什么这三只汽车和工业芯片股票刚刚飙升</li>
<li>道琼斯工业平均指数（DJIA）是什么？</li>
<li>根据 MarketBeat，评级最高的五只股息股票</li>
<li>选举股票：选举如何影响股市</li>
<li>Dollar Tree 的激增和 Home Depot 的下滑对消费者健康的影响</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9T0FCSQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9T0FCSQ"/></p>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 OmniAb 吗？</h2>
<p>在你考虑 OmniAb 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街评级最高和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只股票，顶级分析师正在悄悄地向客户推荐在更广泛的市场注意到之前立即购买……而 OmniAb 并不在名单上。</p>
<p>虽然 OmniAb 目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

OABI

<p>OmniAb 首席执行官 Matthew Foehr 出售了 13,666 股，交易金额为 26,785.36 美元，减少了 0.31% 的持股比例。出售后，他持有 4,360,083 股，价值 8,545,762.68 美元。该交易已在美国证券交易委员会（SEC）备案。OmniAb 的股票开盘价为 1.99 美元，市值为 2.8648 亿美元。分析师对该股票的评级为 “适度买入”，目标价格为 6.67 美元。机构投资者持有该股票的 72.08%</p>

<p>OmniAb, Inc. (NASDAQ:OABI - Get Free Report) CEO Matthew Foehr sold 13,666 shares of the business's stock in a transaction on Monday, December 8th. The shares were sold at an average price of $1.96, for a total value of $26,785.36. Following the completion of the sale, the chief executive officer owned 4,360,083 shares in the company, valued at $8,545,762.68. This represents a 0.31% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link.</p>
<div class="lb-trans"><p>OmniAb, Inc.（纳斯达克代码：OABI - 获取免费报告）首席执行官 Matthew Foehr 于 12 月 8 日星期一出售了 13,666 股公司的股票。股票以平均价格 1.96 美元出售，总价值为 26,785.36 美元。出售完成后，首席执行官在公司中持有 4,360,083 股，价值为 8,545,762.68 美元。这代表其持股比例下降了 0.31%。该交易已在向 SEC 提交的文件中披露，文件可通过此链接获取。</p>
</div><h2>OmniAb Price Performance</h2>
<div class="lb-trans"><h2>OmniAb 价格表现</h2>
</div><p>NASDAQ OABI opened at $1.99 on Tuesday. The company has a market cap of $286.48 million, a P/E ratio of -3.43 and a beta of 0.13. The stock has a 50-day moving average of $1.65 and a two-hundred day moving average of $1.71. OmniAb, Inc. has a 1-year low of $1.22 and a 1-year high of $4.17.</p>
<div class="lb-trans"><p>纳斯达克 OABI 于周二开盘价为 1.99 美元。该公司的市值为 2.8648 亿美元，市盈率为-3.43，贝塔值为 0.13。该股票的 50 日移动平均价为 1.65 美元，200 日移动平均价为 1.71 美元。OmniAb, Inc.的 1 年最低价为 1.22 美元，1 年最高价为 4.17 美元。</p>
</div><p>OmniAb (NASDAQ:OABI - Get Free Report) last issued its quarterly earnings results on Tuesday, November 4th. The company reported ($0.14) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.15) by $0.01. The business had revenue of $2.24 million for the quarter, compared to analysts' expectations of $5.64 million. OmniAb had a negative net margin of 301.83% and a negative return on equity of 23.14%. On average, analysts anticipate that OmniAb, Inc. will post -0.61 EPS for the current fiscal year.</p>
<div class="lb-trans"><p>OmniAb（纳斯达克：OABI - 获取免费报告）最近于 11 月 4 日星期二发布了季度财报。公司报告本季度每股收益（EPS）为-0.14 美元，超出市场共识预期的-0.15 美元 0.01 美元。该季度的收入为 224 万美元，而分析师预期为 564 万美元。OmniAb 的净利润率为-301.83%，股本回报率为-23.14%。分析师平均预计 OmniAb, Inc.在当前财政年度的每股收益为-0.61 美元。</p>
</div><h2>Hedge Funds Weigh In On OmniAb</h2>
<div class="lb-trans"><h2>对 OmniAb 的对冲基金看法</h2>
</div><p>A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Nuveen LLC acquired a new stake in OmniAb during the first quarter worth approximately $547,000. Public Employees Retirement System of Ohio purchased a new position in shares of OmniAb in the 2nd quarter valued at $168,000. PNC Financial Services Group Inc. raised its stake in OmniAb by 279.4% during the 1st quarter. PNC Financial Services Group Inc. now owns 16,276 shares of the company's stock worth $39,000 after acquiring an additional 11,986 shares in the last quarter. Connors Investor Services Inc. lifted its position in OmniAb by 25.0% in the second quarter. Connors Investor Services Inc. now owns 62,000 shares of the company's stock valued at $108,000 after acquiring an additional 12,389 shares during the last quarter. Finally, Towerview LLC boosted its stake in OmniAb by 43.3% in the second quarter. Towerview LLC now owns 831,100 shares of the company's stock valued at $1,446,000 after acquiring an additional 251,100 shares in the last quarter. 72.08% of the stock is owned by institutional investors and hedge funds.</p>
<div class="lb-trans"><p>一些机构投资者和对冲基金最近增加或减少了对该公司的持股。Nuveen LLC 在第一季度收购了 OmniAb 的新股份，价值约为 547,000 美元。俄亥俄州公共雇员退休系统在第二季度购买了 OmniAb 的新股份，价值 168,000 美元。PNC 金融服务集团在第一季度将其在 OmniAb 的持股增加了 279.4%。PNC 金融服务集团目前持有 16,276 股公司股票，价值 39,000 美元，此前在上个季度增持了 11,986 股。Connors 投资服务公司在第二季度将其在 OmniAb 的持股提高了 25.0%。Connors 投资服务公司目前持有 62,000 股公司股票，价值 108,000 美元，此前在上个季度增持了 12,389 股。最后，Towerview LLC 在第二季度将其在 OmniAb 的持股增加了 43.3%。Towerview LLC 目前持有 831,100 股公司股票，价值 1,446,000 美元，此前在上个季度增持了 251,100 股。72.08% 的股票由机构投资者和对冲基金持有。</p>
</div><h2>Analyst Ratings Changes</h2>
<div class="lb-trans"><h2>分析师评级变动</h2>
</div><p>Separately, Weiss Ratings restated a &#34;sell (d-)&#34; rating on shares of OmniAb in a research note on Monday, December 1st. Three investment analysts have rated the stock with a Buy rating and one has given a Sell rating to the company. According to MarketBeat, the stock presently has an average rating of &#34;Moderate Buy&#34; and a consensus target price of $6.67.</p>
<div class="lb-trans"><p>另外，Weiss Ratings 在 12 月 1 日星期一的一份研究报告中重申了对 OmniAb 股票的 “卖出（d-）” 评级。三位投资分析师对该股票给予了买入评级，一位分析师给予了卖出评级。根据 MarketBeat 的数据，该股票目前的平均评级为 “适度买入”，共识目标价为 6.67 美元。</p>
</div><p><strong>View Our Latest Research Report on OABI</strong></p>
<div class="lb-trans"><p><strong>查看我们关于 OABI 的最新研究报告</strong></p>
</div><h2>OmniAb Company Profile</h2>
<div class="lb-trans"><h2>OmniAb 公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>OmniAb, Inc, a biotechnology company, engages in the discovery and provision of therapeutic antibody discovery technologies in the United States. The company's technology platform creates and screens diverse antibody repertoires and identify optimal antibodies for partners' drug development efforts.</p>
<div class="lb-trans"><p>OmniAb, Inc.是一家生物技术公司，专注于在美国发现和提供治疗性抗体发现技术。公司的技术平台创建并筛选多样的抗体库，并为合作伙伴的药物开发工作识别最佳抗体。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>进一步阅读</h2>
</div><ul>
<li>Five stocks we like better than OmniAb</li>
<li>What is a Low P/E Ratio and What Does it Tell Investors?</li>
<li>Why These 3 Automotive &amp; Industrial Chip Stocks Just Soared</li>
<li>What is the Dow Jones Industrial Average (DJIA)?</li>
<li>Top 5 Highest-Rated Dividend Stocks, According to MarketBeat</li>
<li>Election Stocks: How Elections Affect the Stock Market</li>
<li>What Dollar Tree’s Surge and Home Depot’s Slide Say About Consumer Health</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票而非 OmniAb</li>
<li>什么是低市盈率，它对投资者意味着什么？</li>
<li>为什么这三只汽车和工业芯片股票刚刚飙升</li>
<li>道琼斯工业平均指数（DJIA）是什么？</li>
<li>根据 MarketBeat，评级最高的五只股息股票</li>
<li>选举股票：选举如何影响股市</li>
<li>Dollar Tree 的激增和 Home Depot 的下滑对消费者健康的影响</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9T0FCSQ" alt="" original-src="https://www.marketbeat.com/scripts/InsiderTradesChart.ashx?Prefix=NASDAQ&amp;Symbol=OABI"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in OmniAb Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 OmniAb 吗？</h2>
</div><p>Before you consider OmniAb, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑 OmniAb 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and OmniAb wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街评级最高和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只股票，顶级分析师正在悄悄地向客户推荐在更广泛的市场注意到之前立即购买……而 OmniAb 并不在名单上。</p>
</div><p>While OmniAb currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 OmniAb 目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

OmniAb (NASDAQ:OABI) 的首席执行官出售了价值 $26,785.36 的股票